• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

D5抗原(一种雌激素受体相关蛋白)在正常乳腺、乳腺良性疾病及乳腺原位癌中的免疫组织化学研究。

Immunohistochemical study of D5 antigen (an oestrogen receptor related protein) in normal breast, benign breast disease, and mammary carcinoma in situ.

作者信息

Girling A, Caleffi M, King R J, Millis R R

机构信息

Clinical Oncology Unit, Imperial Cancer Research Fund, Guy's Hospital, London.

出版信息

J Clin Pathol. 1988 Apr;41(4):448-53. doi: 10.1136/jcp.41.4.448.

DOI:10.1136/jcp.41.4.448
PMID:2835402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1141474/
Abstract

Patterns of staining with a monoclonal antibody which recognises D5 antigen (a 29,000 kD oestrogen receptor-related protein) were studied in seven normal and 76 benign breast biopsy specimens as well as in 12 cases of pure in situ mammary carcinoma. Staining in benign breast lesions was weak and heterogeneous when compared with that seen in most infiltrating carcinomas. In situ carcinomas showed an intermediate pattern of staining. The finding of only small foci of weak positivity for D5 antigen in normal and benign breast disease indicated that there are similarities between the expression of D5 antigen and the presence of oestrogen receptor protein in these tissues. A further similarity was seen with in situ carcinomas, which have been shown to have lower oestrogen receptor content than infiltrating carcinomas and a more heterogeneous staining pattern with D5 than is seen in infiltrating tumours. The importance of these findings remains to be evaluated because the precise nature of D5 antigen and its association with the oestrogen receptor molecule is not fully understood.

摘要

利用一种识别D5抗原(一种29,000 kD雌激素受体相关蛋白)的单克隆抗体进行染色模式研究,对象包括7例正常乳腺活检标本、76例良性乳腺活检标本以及12例纯原位乳腺癌。与大多数浸润性癌相比,良性乳腺病变中的染色较弱且不均匀。原位癌呈现出中等程度的染色模式。在正常乳腺和良性乳腺疾病中仅发现小灶性D5抗原弱阳性,这表明这些组织中D5抗原的表达与雌激素受体蛋白的存在之间存在相似性。原位癌还存在另一个相似之处,即已证明其雌激素受体含量低于浸润性癌,且与浸润性肿瘤相比,D5染色模式更不均匀。由于D5抗原的确切性质及其与雌激素受体分子的关联尚未完全明了,这些发现的重要性仍有待评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283a/1141474/4d160ee4fd02/jclinpath00336-0092-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283a/1141474/0b6a4926425e/jclinpath00336-0090-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283a/1141474/1825d845b3e4/jclinpath00336-0091-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283a/1141474/4d160ee4fd02/jclinpath00336-0092-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283a/1141474/0b6a4926425e/jclinpath00336-0090-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283a/1141474/1825d845b3e4/jclinpath00336-0091-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283a/1141474/4d160ee4fd02/jclinpath00336-0092-a.jpg

相似文献

1
Immunohistochemical study of D5 antigen (an oestrogen receptor related protein) in normal breast, benign breast disease, and mammary carcinoma in situ.D5抗原(一种雌激素受体相关蛋白)在正常乳腺、乳腺良性疾病及乳腺原位癌中的免疫组织化学研究。
J Clin Pathol. 1988 Apr;41(4):448-53. doi: 10.1136/jcp.41.4.448.
2
Histochemical studies of human breast cancer using a monoclonal antibody against an oestrogen receptor-related antigen.利用抗雌激素受体相关抗原的单克隆抗体对人类乳腺癌进行组织化学研究。
Br J Cancer. 1987 Jun;55(6):611-6. doi: 10.1038/bjc.1987.124.
3
Macrophages in human breast disease: a quantitative immunohistochemical study.人类乳腺疾病中的巨噬细胞:一项定量免疫组织化学研究。
Br J Cancer. 1988 Feb;57(2):174-7. doi: 10.1038/bjc.1988.36.
4
Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.肿瘤相关抗原(DF3)在人乳腺非典型增生及原位癌中的表达。
J Natl Cancer Inst. 1987 Jul;79(1):109-17.
5
Immunohistology of oestrogen receptor and D5 antigen in breast cancer: correlation with oestrogen receptor content of adjacent cryostat sections assayed by radioligand binding and enzyme immunoassay.乳腺癌中雌激素受体与D5抗原的免疫组织学:与通过放射性配体结合和酶免疫测定法检测的相邻低温恒温器切片中雌激素受体含量的相关性。
J Clin Pathol. 1987 Jul;40(7):734-40. doi: 10.1136/jcp.40.7.734.
6
[Small focal lesions of the breast: a clinico-morphological analysis].[乳腺小灶性病变:临床形态学分析]
Arkh Patol. 1984;46(9):25-32.
7
Monoclonal antibody B72.3 in benign breast lesions.单克隆抗体B72.3在乳腺良性病变中的应用
J Clin Pathol. 1990 Dec;43(12):1026-8. doi: 10.1136/jcp.43.12.1026.
8
Comparison of immunoperoxidase staining of 3 different types of CD5 antibodies in a spectrum of breast lesions.3种不同类型CD5抗体在一系列乳腺病变中的免疫过氧化物酶染色比较。
Arch Pathol Lab Med. 2001 Jun;125(6):781-4. doi: 10.5858/2001-125-0781-COISOD.
9
17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.人乳腺导管原位癌及导管内增生性病变中的17β-羟基类固醇脱氢酶1型和2型
Anticancer Res. 2000 Mar-Apr;20(2B):1101-8.
10
Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors.一种新型单克隆抗体(DF3)对人类恶性与良性乳腺肿瘤的不同反应性。
Hybridoma. 1984 Fall;3(3):223-32. doi: 10.1089/hyb.1984.3.223.

引用本文的文献

1
A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer.一种27千道尔顿的热休克蛋白,在早期和晚期乳腺癌中具有异常的预后预测能力。
Br J Cancer. 1994 Apr;69(4):743-8. doi: 10.1038/bjc.1994.140.

本文引用的文献

1
Estradiol and progesterone receptors in human breast fibroadenomas.人乳腺纤维腺瘤中的雌二醇和孕酮受体
J Clin Endocrinol Metab. 1981 Jun;52(6):1225-9. doi: 10.1210/jcem-52-6-1225.
2
Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast.乳腺良性纤维囊性疾病中类固醇受体与上皮细胞增殖之间的关系。
Cancer. 1982 Jun 15;49(12):2534-6. doi: 10.1002/1097-0142(19820615)49:12<2534::aid-cncr2820491221>3.0.co;2-j.
3
Most cystosarcoma phyllodes and fibroadenomas have progesterone receptor but lack estrogen receptor: stromal localization of progesterone receptor.
Cancer. 1981 Apr 15;47(8):2016-21. doi: 10.1002/1097-0142(19810415)47:8<2016::aid-cncr2820470819>3.0.co;2-v.
4
Oestradiol receptors in carcinoma and benign disease of the breast: an in vitro assay.乳腺癌及乳腺良性疾病中的雌二醇受体:一项体外检测
Br J Cancer. 1971 Dec;25(4):697-710. doi: 10.1038/bjc.1971.85.
5
Monoclonal antibodies against a component related to soluble estrogen receptor.针对与可溶性雌激素受体相关成分的单克隆抗体。
Cancer Res. 1985 Aug;45(8):3686-93.
6
Risk factors for breast cancer in women with proliferative breast disease.患有增生性乳腺疾病的女性患乳腺癌的风险因素。
N Engl J Med. 1985 Jan 17;312(3):146-51. doi: 10.1056/NEJM198501173120303.
7
Histochemical studies with an estrogen receptor-related protein in human breast tumors.人乳腺肿瘤中雌激素受体相关蛋白的组织化学研究。
Cancer Res. 1986 Dec;46(12 Pt 1):6475-80.
8
Oestrogen receptor activity in intraduct and invasive breast carcinomas.导管内癌和浸润性乳腺癌中的雌激素受体活性
Breast Cancer Res Treat. 1987;9(2):129-33. doi: 10.1007/BF01807365.
9
Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features.良性乳腺肿瘤和病变中的雌激素和孕激素受体:与组织学和细胞学特征的关系。
Int J Cancer. 1986 Jan 15;37(1):7-10. doi: 10.1002/ijc.2910370103.
10
Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium.
Cancer Res. 1985 Nov;45(11 Pt 2):5728-33.